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Near-infrared spectroscopy (NIRS) is a noninvasive neuroimaging tool used to measure activation-
induced changes in cerebral hemoglobin concentration. By this technique, changes in the optical ab-
sorption of light are recorded over time and are used to estimate the functionally evoked changes in
cerebral oxyhemoglobin and deoxyhemoglobin concentrations that result from local cerebral vascular
and oxygen metabolic effects during brain activities. Over the past decades, it has become a frequently
used technique in psychiatry studies such as depression, schizophrenia, and Alzheimer’s disease.
Compared to positron emission tomography or magnetic resonance imaging, NIRS has the advantages of
having higher temporal resolution, being easier to perform, and the ability to use portable equipment.
Because of its growing popularity and promising perspectives in clinical applications, we review Alz-
heimer’s disease-related studies using NIRS methodology in this article. The existing evidence shows that
NIRS might have the potential to become either a disease- or syndrome-speciﬁc diagnostic tool in the
future. However, larger studies with more study participants are needed to establish disease-speciﬁc
sensitivity and speciﬁcity.
Copyright  2013, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC.  Open access under CC BY-NC-ND license.1. Introduction
Near-infrared spectroscopy (NIRS) is a noninvasive optical in-
strument designed for the evaluation of tissue oxygenation and
hemodynamics.1 It uses the near-infrared spectrum (650e850 nm
wavelength) to monitor changes in concentration of oxyhemo-
globin [HbO2] and deoxyhemoglobin [HbR] in vivo. Light from the
near-infrared spectrum can penetrate the skull and is absorbed
mainly by oxy-Hb and deoxy-Hb, which have different absorption
spectra. Changes of the oxy-Hb and deoxy-Hb in the brain tissue
can be calculated from the amount of absorbed near-infrared light
using the modiﬁed Lambert-Beer Law. These characteristics enable
NIRS to determine relative changes in the [HbO2] and [HbR] by
emitting near-infrared light at several different wavelengths into
brain tissue and detecting their remnants.2e4 In this way, summa-
tion of changes in oxy-Hb [HbO2] and deoxy-Hb [HbR] gives
changes in the total hemoglobin concentration ([HbT]), which re-
ﬂects those in blood volume, and changes in [HbO2] and [HbR] are
related to changes in cerebral metabolic rates, and changes in [HbT]
are related to those in cerebral blood ﬂow.5 This characteristicFaculty of Medicine, National
ad, Taichung 407, Taiwan.
linical Gerontology & Geriatrics. Penables NIRS to measure the regional neurovascular coupling of
neural activation.6,7 Because more blood ﬂows to an activated re-
gion in the brain, as a proof of principle, NIRS may be used to detect
functional changes. Currently, a number of functional brain acti-
vation studies have shown that NIRS is a suitable method of
detecting changes in the [HbO2] and [HbR] cognitive tests.1,8e10
Alzheimer’s disease (AD) is a progressive neurodegenerative
disease deﬁned as a clinical condition of declining function in
various cognitive domains, such as memory, reasoning, judgment,
executive function, praxis, visuospatial abilities, and language. As
cognitive disturbances occur in AD, NIRS may help to detect
disease-speciﬁc alterations in the brain that may be either of
diagnostic value and/or useful for therapeutic monitoring. So far,
activation-induced changes in NIRS variables have been demon-
strated in several AD-related studies.11 The aim of this article is to
review the present studies of NIRS in AD; possible future clinical
applications as shown in Table 1.
2. Age-dependent changes in cerebral hemoglobin
oxygenation during brain activation
NIRS is able to detect age-related changes in brain function, as
Hock et al showed that increase in cerebral Hb oxygenation in
response to brain activation declines with physiological aging.12
Their study examined 29 individuals, including 12 healthy youngublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
Table 1
Description of included Alzheimer’s disease-related near-infrared spectroscopy (NIRS) studies.
Ref. n Study participants NIRS machinea Activation task Main ﬁndings
12 29 12 young healthy volunteers
17 elderly healthy volunteers
NIRO 500 system Calculation task Regression analysis supports the hypothesis of
an age-dependent decline in the activation-
induced local increase in [HbO2] as well as [HbT]
13 38 19 healthy elderly volunteers
19 patients with probable moderate AD
according to NINCDS-ADRDA criteria
NIRO 500 system VFT Patients with AD showed more pronounced
decrease in [HbO2] and [HbT] in the parietal
cortex than in the frontal cortex
15 20 10 healthy controls
10 patients with AD according to DSM-IV and
NINCDS-ADRDA criteria
Critikon 2020 Cerebral
RedOx Monitor
VFT Patients with AD did not show the
predominantly left hemispheric activation as
observed in healthy controls during VFT
18 21 8 patients without memory complaints
13 patients with subjective memory
complaints, mild cognitive impairment, or very
mild AD
NIRO 300 system Olfactory stimulation
with vanilla
There is signiﬁcant difference in response to
vanilla stimuli between the patient and control
groups
19 32 16 healthy controls
16 patients with AD according to ICD-10 criteria
ETG-100 VFT There is reduced increase of [HbO2] in the
dorsolateral prefrontal cortex in patients with
AD
20 62 32 healthy controls
15 individuals with MCI
15 patients with AD according to
NINCDSeADRDA criteria
ETG-7000 VFT Compared to the control group, the amplitude
of changes in the oxy-Hbwaveform (A-Index) in
the frontal and bilateral areas is signiﬁcantly
lower in the AD group, whereas A-Index in the
MCI group was signiﬁcantly lower only in the
right parietal area
21 26 13 healthy controls
13 patients with suspected mild AD according
to ICD-10 criteria
ETG-100 Benton Line Orientation
Task
During the spatial task, healthy individuals
showed explicit parietal activation, whereas AD
patients displayed only activation during the
control task
AD ¼ Alzheimer’s disease; DSM-IV ¼ Diagnostic and Statistical Manual of Mental Disorders, 4th edition; [HbO2] ¼ concentration of oxy-hemoglobin; [HbT] ¼ concentration of
total hemoglobin; ICD-10¼ International Classiﬁcation of Diseases, 10th revision; MCI¼mild cognitive impairment; NINCDSeADRDA¼ National Institute of Neurological and
Communicative Disorders and Stroke and the Alzheimer’s Disease and Related Disorders Association; VFT ¼ verbal ﬂuency test.
a Critikon 2020 Cerebral RedOx Monitor, Johnson & Johnson Medical, New Brunswick, NJ, USA; ETG-100 and ETG-7,000, made jointly by Hitachi Ltd., Tokyo, and Hitachi
Medical Corp., Chiba, Japan; NIRO-500 and NIRO-300 systems, Hamamatsu Photonic Corporation, Osaka, Japan.
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young group, the elderly participants showed a signiﬁcantly lower
mean increase in [HbO2] and [HbT] levels in the frontal cortex
during performing calculation tasks. Further regression analysis
supports the hypothesis of an age-dependent decline in activation-
induced regional increase of [HbO2]. It was hypothesized that the
age-dependent decline may be due to activation of other brain
regions during mental task because of altered brain organization,
or secondly, to an alteration of neurovascular coupling that atten-
uates the temporary mismatch between oxygen delivery and
consumption.6
3. AD phenotype study
3.1. Changes in cerebral hemoglobin oxygenation during different
mental tasks in AD patients
Hock et al examined 38 individuals, including 19 healthy elderly
volunteers and 19 patients with probable moderate AD according
to the National Institute of Neurological and Communicative Dis-
orders and Stroke criteria.13,14 They observed that healthy partici-
pants showed an increase in [HbO2] and [HbT] and a slight decrease
in [HbR]. By contrast, most patients with AD showed a decrease in
[HbO2] and [HbT] during the verbal ﬂuency test (VFT). This phe-
nomenon is more pronounced in the parietal cortex than in the
frontal cortex. The possible mechanism could result from altered
regional brain function, altered neurovascular coupling caused by
neurodegeneration, or anatomical changes during aging and
neurodegeneration.
In another study conducted by Fallgatter et al,15 which included
10 patients with AD and 10 healthy controls, NIRS showed that the
patients lost the predominantly left hemispheric activations
observed in controls during VFT. Previous NIRS studies showed a
general decrease in [HbO2] associated with normal aging withoutloss of hemispheric asymmetries.12,14,16 Therefore, this ﬁnding with
loss of asymmetry during VFT is possibly characteristic for AD.
4. Measurement of the temporal lobe with NIRS
The medial temporal lobe, including the entorhinal cortex,
amygdala, and hippocampus, is one of the ﬁrst regions of the brain
to show AD-related neurodegeneration. The observed memory
declines in the early and prodromal stages of AD are probably
associated with degeneration of the medial temporal lobe, espe-
cially in the entorhinal cortex and hippocampus.17 A preliminary
feasibility study of NIRS conducted by Fladby et al18 revealed
impaired response to olfactory stimulation in the temporal cortex
in 13 individuals with subjective memory complaints, mild cogni-
tive impairment (MCI), or very mild AD. Because the pathway for
the olfactory response is through the entorhinal cortex, the
response may be diminished at an early stage of AD. Therefore,
NIRS might be a promising method in the detection of temporal
lobe dysfunction in AD.
5. Monitoring therapeutic effects of medications
NIRS also demonstrated possible clinical usage in the future for
monitoring effects of medications, such as cholinesterase inhibitor.
Herrmann et al used multichannel NIRS to investigate 16 patients
with AD and 16 healthy individuals during the performance of
VFT.19 They found reduced increase of [HbO2] in the dorsolateral
prefrontal cortex in patients with AD. These results might be of
relevance for future therapeutic studies, for a previous study
showing that AD patients who respond to cholinesterase inhibitor
were characterized by bilateral lower dorsolateral frontal perfu-
sion.20 It would be beneﬁcial to measure the signiﬁcance of brain
activation for the efﬁcacy of cholinesterase inhibitors with NIRS in
the future.
Table 2
Comparisons among different functional brain tests.
Method Target of
measurement
Spatial
resolution
Temporal
resolution
Cost
PET Blood ﬂow Medium Low High
SPECT Blood ﬂow Medium Low Medium
EEG Neuron activity Low High Low
NIRS Blood ﬂow Low High Low
fMRI Blood ﬂow High Medium Medium
EEG ¼ electroencephalography; fMRI ¼ functional MRI; NIRS ¼ near-infrared
spectroscopy; PET ¼ positron emission tomography; SPECT ¼ single-photon emis-
sion computed tomography.
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In the study by Arai et al,21 consisting of 32 healthy controls, 15
individuals diagnosed with MCI, and 15 patients with AD. By
calculation of the activation index, the amplitude of changes in the
[HbO2] waveform in each area during the activation task, they
found that the activation index was signiﬁcantly lower in the
frontal, and bilateral parietal areas in the AD group, whereas [HbO2]
in the MCI group was signiﬁcantly lower only in the right parietal
area. Thus, NIRS has the potential to be a primary screening tool for
AD in the community health care system in the future.
Zeller et al investigated the visuospatial deﬁcits among 13 pa-
tients with suspected mild AD using the Benton line orientation
task.22 Interestingly, they found no difference in task performance
between patients and controls. However, NIRS showed activation
deﬁcits in the parietal lobe in patients with AD. This implies that
NIRS could possibly be developed into an early detection method in
the future.
7. Relationship between NIRS and functional magnetic
resonance image
A number of simultaneous NIRS and functional magnetic reso-
nance image (fMRI) experiments have beenperformed to investigate
the relationship between NIRS and blood-oxygen level-dependent
(BOLD) signals in common regions of the brain, which have shown
that there is a good correlation between the NIRS-recorded func-
tional Hb response and the local BOLD signal.23e26
Recently, several studies also begin to investigate the relation-
ship between NIRS and fMRIeBOLD during the resting state, i.e.,
when no stimulation paradigm is applied.27,28 The results also
showed a signiﬁcant correlation between NIRS signals and fMRIe
BOLD data across the whole brain volume even during the resting
state.
8. Limitations of the present NIRS methodology
As shown in Table 2, in comparison with other functional brain
images, advantages of NIRS include high temporal resolution, direct
measurement of hemodynamic changes of brain, lower cost, and
ease of portability and application.11,29,30
However, the clinical use of the present implementation of the
NIRS method is hampered by several limitations.11 First, the abso-
lute baseline [HbO2] and [HbR] cannot be obtained. The quantiﬁ-
cation of absolute hemoglobin concentration changes is dependent
on knowledge of the different path-length and partial volume
factors.2,31 Although the propagation of light through tissue can
either be modeled by using light transport theory32e34 or be
measured experimentally,35,36 most NIRS experiments do not have
access to this information, as this generally requires an additional
MRI or computed axial tomography scan to provide anatomical
information.37,38 Several groups have tabulated values of thedifferential and partial path-length factors.35,36,39,40 However, un-
certainty in these factors will ultimately limit the quantitative
ability of NIRS to measure absolute hemoglobin concentration
changes because the path traveled by light through cortical tissue
varies with the wavelength-dependent scattering properties of the
head and head layers37,40,41 and may be minimized by an optimal
choice of wavelength pairs.37,40,42 Second, NIRS measures Hb con-
centration in the cortex region but not in deeper brain structures.
Common brain structures involved in AD, such as the para-
hippocampal gyrus and hippocampus regions, are located deeper in
the brain and hence could not be measured. Third, current studies
mainly consisted of small numbers of study participants; larger
studies with more participants might be needed for sensitivity or
speciﬁcity study in the future.
9. Conclusions and future directions
The NIRS technology is a noninvasive and portable bedside tool
able to detect signals related to neuronal activity in the cerebral
cortex, which is of potential interest to clinical neuropsychiatry.
Reviewing the present studies leads to the conclusion that alter-
ations in cerebral hemoglobin oxygenation due to cognitive dis-
turbances in AD may be a target of future investigations. NIRS may
have the potential to become either a disease- or a syndrome-
speciﬁc diagnostic tool. Although the clinical use of the present
implementations of NIRS methods is still hampered by several
limitations, along with the increasing applications for the tech-
nology, NIRS technology will continue to make advances toward
the understanding of the functioning of the human brain.
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